DK345889A - Anvendelse af 5-ht-3-receptorantagonist - Google Patents

Anvendelse af 5-ht-3-receptorantagonist Download PDF

Info

Publication number
DK345889A
DK345889A DK345889A DK345889A DK345889A DK 345889 A DK345889 A DK 345889A DK 345889 A DK345889 A DK 345889A DK 345889 A DK345889 A DK 345889A DK 345889 A DK345889 A DK 345889A
Authority
DK
Denmark
Prior art keywords
pct
receptor antagonist
sec
treatment
date
Prior art date
Application number
DK345889A
Other languages
Danish (da)
English (en)
Other versions
DK345889D0 (da
Inventor
Andrew James Williams
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878726717A external-priority patent/GB8726717D0/en
Priority claimed from GB878726716A external-priority patent/GB8726716D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of DK345889D0 publication Critical patent/DK345889D0/da
Publication of DK345889A publication Critical patent/DK345889A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Electrotherapy Devices (AREA)
  • Conductive Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
DK345889A 1987-11-14 1989-07-12 Anvendelse af 5-ht-3-receptorantagonist DK345889A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878726717A GB8726717D0 (en) 1987-11-14 1987-11-14 Treatment
GB878726716A GB8726716D0 (en) 1987-11-14 1987-11-14 Treatment
PCT/GB1988/000994 WO1989004660A1 (en) 1987-11-14 1988-11-14 5-ht3 receptor antagonists for treatment of cough and bronchoconstriction

Publications (2)

Publication Number Publication Date
DK345889D0 DK345889D0 (da) 1989-07-12
DK345889A true DK345889A (da) 1989-07-12

Family

ID=26293045

Family Applications (1)

Application Number Title Priority Date Filing Date
DK345889A DK345889A (da) 1987-11-14 1989-07-12 Anvendelse af 5-ht-3-receptorantagonist

Country Status (9)

Country Link
US (1) US5098909A (de)
EP (1) EP0340270B1 (de)
JP (1) JPH02502185A (de)
KR (1) KR890701099A (de)
AT (1) ATE78162T1 (de)
AU (1) AU616706B2 (de)
DE (1) DE3872872T2 (de)
DK (1) DK345889A (de)
WO (1) WO1989004660A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8072691A (en) * 1990-06-28 1992-01-23 Beecham Group Plc Pharmaceutical preparations
HU211081B (en) * 1990-12-18 1995-10-30 Sandoz Ag Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
AU2295792A (en) * 1991-06-26 1993-01-25 Sepracor, Inc. Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
CA2371822A1 (en) 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
CN1355698A (zh) * 1999-06-15 2002-06-26 呼吸器有限公司 可用作治疗有关支气管收缩的机能障碍的药物的化合物
GB9918425D0 (en) * 1999-08-04 1999-10-06 Novartis Ag Organic compounds
WO2001095903A1 (en) * 2000-06-15 2001-12-20 Respiratorius Ab 5-ht3 receptor antagonists for treatment of disorders involving airway constriction
PL210065B1 (pl) 2002-09-25 2011-11-30 Memory Pharm Corp Związki indazole, benzotiazole i benzoizotiazole, kompozycje farmaceutyczne je zawierające oraz zastosowanie związków
WO2004091606A1 (en) * 2003-04-16 2004-10-28 Orchid Chemicals & Pharmaceuticals, Ltd. Treatment of bronchial asthma using 5-ht3 receptor antagonists
BRPI0417323A (pt) 2003-12-22 2007-03-27 Memory Pharm Corp indóis, 1h-indazóis, 1,2-benzisoxazóis, e 1,2-benzisotiazóis, composto, composição farmacêutica e usos dos mesmos
CA2560741C (en) 2004-03-25 2013-08-06 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
JP2007534692A (ja) * 2004-04-22 2007-11-29 メモリー・ファーマシューティカルズ・コーポレイション インドール、１ｈ−インダゾール、１，２−ベンズイソキサゾール、１，２−ベンゾイソチアゾール、ならびにその調製および使用
DE602005027452D1 (de) * 2004-05-07 2011-05-26 Memory Pharm Corp 1h-indazole, benzothiazole, 1,2-benzisoxazole, 1,2-benzisothiazole und chromone und deren herstellung und verwendungen
AU2005319248A1 (en) * 2004-12-22 2006-06-29 Memory Pharmaceuticals Corporation Nicotinic alpha-7 receptor ligands and preparation and uses thereof
US8106066B2 (en) * 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687080T2 (de) * 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.

Also Published As

Publication number Publication date
ATE78162T1 (de) 1992-08-15
DK345889D0 (da) 1989-07-12
WO1989004660A1 (en) 1989-06-01
AU2626488A (en) 1989-06-14
JPH02502185A (ja) 1990-07-19
DE3872872T2 (de) 1993-02-04
US5098909A (en) 1992-03-24
AU616706B2 (en) 1991-11-07
EP0340270A1 (de) 1989-11-08
DE3872872D1 (de) 1992-08-20
EP0340270B1 (de) 1992-07-15
KR890701099A (ko) 1989-12-19

Similar Documents

Publication Publication Date Title
DK345889A (da) Anvendelse af 5-ht-3-receptorantagonist
NO2015027I2 (no) Mepolizumab
FI873738A7 (fi) Menetelmä tekstiilipintojen käsittelemiseksi ja siinä käytetty seos.
BR9506305A (pt) Aparelho e processo para preparação de formas sólidas com desprendimento controlado do ingrediente ativo
DK0804196T3 (da) Anvendelse af serotoninantagonister (5HT 3) til behandling af fibromyalgia
DE69033487D1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
DE3876273D1 (de) Isoelektrisches fokussierverfahren sowie einrichtung zur durchfuehrung dieses verfahrens.
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
IT1196645B (it) Apparecchio per l'2nfilamento e losfilamento automatico di tubolari,come calze e calzamaglie,in apparecchi di ispezione
IT8367542A0 (it) Bocchettone di scarico per apparecchi igienico sanitari e simili
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
BE878806A (fr) Composition de blanchiment photographique et procede de traitement photographique l'utilisant
FI880954A7 (fi) Seos ja menetelmä immunologista kastrointia varten.
BR9508406A (pt) Uso de um composto e método para o tratamento e/ou profilaxia em mamíferos
ES545155A0 (es) Procedimiento para la obtencion de (pirrol-1-il)-fenil-dihi-dropiridazinona
ES2057910T3 (es) Procedimiento y dispositivo para la obtencion de caseina beta.
DE3587499D1 (de) Primycinkomponenten und verfahren zur trennung des antibiotischen komplexes.
DK0537313T3 (da) Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet
DK149590C (da) Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
NO874241D0 (no) Terapeutisk aktive salter.
ATE128871T1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
DK141188A (da) Fremgangsmaade til direkthydrogenering af smoerfedt

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment